News & Updates: HRT

2019

The deadline to file claims has been extended September 19, 2016.

2015

Pharma firm pays $13M settlement in hormone-replacement lawsuit

2014

CTV News Report On HRT

Klein Lyon’s Hormone Replacement Therapy Class Action lawsuit featured on CTV News.CTV-News-Report-on-HRT

2014

La Presse : Un traitement hormonal aurait-il causé des cancers du sein?

La Presse : Un traitement hormonal aurait-il causé des cancers du sein?
2014

Cancer linked to menopause drug in new report

Toronto Star: Cancer linked to menopause drug in new report
2014

Notice of Certification: Hormone Therapy Class Action

The Supreme Court of British Columbia has ordered publication of Notice of Certification in the Hormone Therapy Class Action.  Women in Canada who were diagnosed with breast cancer after taking Premarin in combination with progestin or Premplus may be able to join the class action. If you do not live in British Columbia you must opt-in before Monday, August 25, 2014 to participate. If you have any questions, please contact Klein Lawyers.

2013

May 29, 2013

On May 29, 2013, we were successful in the BC Court of Appeal.
The Defendants were trying to limit the questions we could ask their former employees. But Justice Gropper ruled that our questions were relevant and material to when Wyeth knew or should have known about the link between hormone replacement therapy and the development of breast cancer. Madame Justice Prowse of the B.C. Court of Appeal agreed; she denied the Defendants attempt to appeal Justice Gropper’s decision. To read Madam Justice Prowse’s decision please click on the following link to the Court website: www.courts.gov.bc.ca/jdb-txt/CA/13/02/2013BCCA0256.htm

2012

April 7, 2012

About 100 women signed onto a class action lawsuit that alleges Wyeth Canada Inc. knowingly supplied a hormone replacement therapy drug called Premarin, which has been linked to breast cancer, between 1977 and 2003. By Christine Wood, Coast Reporter (131 KB)

2011

CBC Radio: Medical Ghostwriting

CBC Radio: Medical Ghostwriting (266 KB)
2011

Class action lawsuit launched from Sechelt

Class action lawsuit launched from Sechelt (193 KB)

2011

Class-action suit OK’d: Breast cancer patients can sue drugmaker

Class-action suit OK’d: Breast cancer patients can sue drugmaker (193 KB)

2011

Judge certifies class-action lawsuit against hormone therapy drugmakers

Judge certifies class-action lawsuit against hormone therapy drugmakers(72 KB)

2011

Class action suit linking drugs, cancer approved

Class action suit linking drugs, cancer approved (119 KB)

2011

Class Action Lawsuit against Wyeth to be Joined by Women in Canada

Class Action Lawsuit against Wyeth to be Joined by Women in Canada(221 KB)

2011

B.C. court certifies breast cancer class action

 B.C. court certifies breast cancer class action (72 KB).

2011

HRT class action case on breast cancer OK’d

HRT class action case on breast cancer OK’d (270 KB)

2011

Class-action breast cancer lawsuit approved

Class-action breast cancer lawsuit approved (328 KB)

2011

Court certifies breast cancer class-action lawsuit

Court certifies breast cancer class-action lawsuit (382 KB)

2011

Woman sues after menopause drug gives her breast cancer

Woman sues after menopause drug gives her breast cancer (221 KB)

2011

Court Certifies Class Action for Canadian Women Harmed by HRT

Court Certifies Class Action for Canadian Women Harmed by HRT (72KB)

2009

Healthzone.ca: Ghostwriting is bad medicine

 Healthzone.ca: Ghostwriting is bad medicine (45 KB)

2008

Media coverage related to Madam Justice Gropper’s decision

Media coverage related to Madam Justice Gropper’s decision (120 KB)

2008

June 27, 2008

On June 27, 2008 Madam Justice Gropper issued Reasons for Judgement holding that the American corporate defendants in this lawsuit, all members of the Wyeth pharmaceuticals conglomerate, fall within the jurisdiction of B.C.’s courts and may be held responsible to Canadian consumers. (See February 2007 entry below for further discussion of this issue.) The American defendants have 30 days to decide whether to appeal the decision of Madam Justice Gropper. If they do not, the next significant step in this lawsuit will be the “certification hearing” during which the Plaintiff will request a court order designating this action as a class action. It will be several months before the certification hearing can take place. See the Reasons of Madam Justice Gropper (102 KB) issued June 27, 2008.

2007

Feb 2007

Before a lawsuit can be considered a class action, the Plaintiff has to apply to have it “certified” by the court. The certification hearing in this case will not take place until the case management judge, Madam Justice Gropper, has heard a “jurisdiction application” filed by all of the American Defendants. The American Wyeth companies have filed documents with the Supreme Court of British Columbia requesting a stay of this action against them on the grounds that the court has no jurisdiction over them. The date for the hearing of the jurisdiction application is not yet known.

2007

Wyeth loses Prempro trial, ordered to pay $1.5 million in damages

Wyeth loses Prempro trial, ordered to pay $1.5 million in damages (73 KB)

2006

Canadian, U.S. breast cancer rates drop

Canadian, U.S. breast cancer rates drop (89 KB)

2006

Reduced hormone therapy use may be cause of steep decline in breast cancer cases

Reduced hormone therapy use may be cause of steep decline in breast cancer cases (60 KB)

2006

Decline in breast cancer cases likely linked to reduced use of hormone replacement

Decline in breast cancer cases likely linked to reduced use of hormone replacement (89 KB)

2002

What The Experts are Saying Now: A Round-Up of International Opinion

What The Experts are Saying Now: A Round-Up of International Opinion (34 KB)

2002

Increased Risk of Ovarian Cancer Is Linked to Estrogen Replacement Therapy

Increased Risk of Ovarian Cancer Is Linked to Estrogen Replacement Therapy (22 KB)

2002

Hormone therapy raises risk of breast cancer recurrence

Hormone therapy raises risk of breast cancer recurrence (20 KB)

2002

Canadian Cancer Society announces recommendation about combined hormone replacement therapy

Canadian Cancer Society announces recommendation about combined hormone replacement therapy (15 KB)

2002

Health Canada: Benefits and risks of combined (estrogen and progestin) Hormone Replacement Therapy

Health Canada: Benefits and risks of combined (estrogen and progestin) Hormone Replacement Therapy (74 KB)

1995

Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus

Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus (72 KB)